| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Veracyte, Inc. (VCYT) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 33 sells. VCYT is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 318.6K | $12.88M | - | |
| CFO | 109.5K | $4.43M | - | |
| Other | 89.5K | $3.62M | - | |
| Other | 82.1K | $3.32M | - | |
| VP | 67.8K | $2.74M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2021 | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sale+OE | 52,015 | $49.36 | $2,567,271.28 | -8.1% | |
| Feb 25, 2021 | Eastham Karin67 | Director | Sale+OE | 6,250 | $60.70 | $379,358.58 | -60.9% | |
| Jan 13, 2021 | Anderson Bonnie H72 | Chairman And CEO | Sale+OE | 18,541 | $51.05 | $946,462.13 | -4.2% | |
| Jan 12, 2021 | Anderson Bonnie H72 | Chairman And CEO | Sale+OE | 91,459 | $50.53 | $4,621,075.16 | -6.6% | |
| Jan 4, 2021 | Gordon Kevin K51 | Director | Sale+OE | 10,000 | $48.98 | $489,798.36 | -64.4% | |
| Dec 4, 2020 | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sale+OE | 14,015 | $56.88 | $797,156.16 | -5.3% | |
| Nov 12, 2020 | Gordon Kevin K51 | Director | Sale+OE | 10,000 | $47.11 | $471,137.52 | -84.7% | |
| Nov 11, 2020 | Ho Mark | Principal Accounting Officer | Sell | 13,875 | $45.00 | $624,375.00 | -42.1% | |
| Nov 6, 2020 | Hanna John Walter Jr | Chief Commercial Officer | Sale+OE | 21,250 | $43.44 | $923,106.29 | -12.4% | |
| Nov 5, 2020 | Hanna John Walter Jr | Chief Commercial Officer | Sale+OE | 6,406 | $40.69 | $260,650.93 | -2.8% |